Literature DB >> 12371123

Skin and soft tissue infections in injection drug users.

John R Ebright1, Barbara Pieper.   

Abstract

Skin and soft tissue infections are the most common cause for hospital admission of injection drug users. Cutaneous and subcutaneous abscesses are the most frequent type of SSTI and occur most commonly when drug users are no longer able to inject intravenously and resort to injection directly into skin or muscle. Abscesses may be difficult to differentiate from uncomplicated cellulitis or may be confused with pseudoaneurysms, hematoma, phlegmon, or thrombosed vein. Special studies, including ultrasonography; CT scans, and MR imaging; or careful incision and inspection may be necessary to clarify the extent of infection and the presence of abscess. These procedures may also help differentiate a subcutaneous abscess from a vascular structure. Uncomplicated cellulitis most commonly responds to antibiotic therapy directed toward Staphylococcus aureus and Streptococcus spp. In several recent studies, cutaneous and subcutaneous abscesses have been found to be caused by polymicrobial infections and to include anaerobic organisms as well as aerobic gram-positive cocci in a little more than 50% of cases. Complete, often repeated, incision and drainage is a prerequisite for successful outcome in these cases. Complications of SSTI are many and are potentially life threatening. They include direct extension of subcutaneous abscess into vital areas or structures, necrotizing fasciitis and myositis, bacteremia, and sepsis. An outbreak of a highly lethal SSTI that recently occurred in Scotland, Ireland, and England seems to have resulted from infection with Clostridia spp, including C. novyi and C. perfringens. A rare but well-documented SSTI in injection drug users is pyomyositis, an abscess-forming infection of skeletal muscle. More than 20 cases have been reported in temperate climates to date. Although not life-threatening, chronic cutaneous venous ulcers of the lower extremities are common and debilitating, requiring long-term multidisciplinary care for successful healing.

Entities:  

Mesh:

Year:  2002        PMID: 12371123     DOI: 10.1016/s0891-5520(02)00017-x

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  56 in total

1.  Prevalence and risk factors for MRSA nasal colonization among persons experiencing homelessness in Boston, MA.

Authors:  Jessica H Leibler; Casey León; Lena J P Cardoso; Jennifer C Morris; Nancy S Miller; Daniel D Nguyen; Jessie M Gaeta
Journal:  J Med Microbiol       Date:  2017-08       Impact factor: 2.472

Review 2.  Tropical pyomyositis (myositis tropicans): current perspective.

Authors:  S Chauhan; S Jain; S Varma; S S Chauhan
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

3.  Risk practices associated with bacterial infections among injection drug users in Denver, Colorado.

Authors:  Kristina T Phillips; Michael D Stein
Journal:  Am J Drug Alcohol Abuse       Date:  2010-03       Impact factor: 3.829

4.  Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.

Authors:  Hudson Reddon; Evan Wood; Mark Tyndall; Calvin Lai; Robert Hogg; Julio Montaner; Thomas Kerr
Journal:  AIDS Educ Prev       Date:  2011-10

5.  Drug use generations and patterns of injection drug use: Birth cohort differences among people who inject drugs in Los Angeles and San Francisco, California.

Authors:  Ricky N Bluthenthal; Lynn Wenger; Daniel Chu; Philippe Bourgois; Alex H Kral
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

6.  Potentiating effect of morphine on oral Salmonella enterica serovar Typhimurium infection is μ-opioid receptor-dependent.

Authors:  Jessica M Breslow; Pu Feng; Joseph J Meissler; John E Pintar; John Gaughan; Martin W Adler; Toby K Eisenstein
Journal:  Microb Pathog       Date:  2010-08-03       Impact factor: 3.738

7.  Effect of filtration on morphine and particle content of injections prepared from slow-release oral morphine tablets.

Authors:  Stuart McLean; Raimondo Bruno; Susan Brandon; Barbara de Graaff
Journal:  Harm Reduct J       Date:  2009-12-22

8.  Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: a cohort study.

Authors:  Elisa Lloyd-Smith; Evan Wood; Ruth Zhang; Mark W Tyndall; Sam Sheps; Julio S G Montaner; Thomas Kerr
Journal:  BMC Public Health       Date:  2010-06-09       Impact factor: 3.295

9.  Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.

Authors:  M Bradley Drummond; Gregory D Kirk; Erin P Ricketts; Meredith C McCormack; J Christian Hague; John F McDyer; Shruti H Mehta; Eric A Engels; Robert A Wise; Christian A Merlo
Journal:  BMC Pulm Med       Date:  2010-05-11       Impact factor: 3.317

10.  The perspectives of injection drug users regarding safer injecting education delivered through a supervised injecting facility.

Authors:  Danya Fast; Will Small; Evan Wood; Thomas Kerr
Journal:  Harm Reduct J       Date:  2008-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.